Ophthalmology

Top Story

Speaker: FDA approval of KXL System ‘a major advancement’

Speaker: FDA approval of KXL System ‘a major advancement’
May 6, 2016

NEW ORLEANS — The FDA approval of the KXL System for corneal collagen cross-linking is a major advancement in the treatment of progressive keratoconus, according to a speaker here.

“We as corneal specialists and our patients can look forward to use of corneal collagen cross-linking, which certainly is a major advancement in treatment of keratoconus,” Peter S. Hersh, MD, said during Cornea Day preceding the American Society of Cataract and Refractive Surgery meeting.

Meeting News Coverage

Surgeon: Patients need to be educated on dangers of cosmetic iris implants

May 6, 2016
NEW ORLEANS — Patients who are interested in receiving cosmetic iris implants to change the color of their eyes need to be educated on the ocular complications…
Meeting News CoverageVideo

VIDEO: Fundus automated perimetry brings added value to retinal imaging

May 6, 2016
NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, Ike K. Ahmed, MD, describes the added value that the CenterVue Compass fundus automated…
Meeting News CoverageVideo

VIDEO: IV-free anesthesia contributes to 'smooth patient experience'

May 6, 2016
NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, Y. Ralph Chu, MD, describes how the Imprimis MKO Melt troche contributes to a "smooth…
Meeting News CoverageVideo

VIDEO: Microperimetry useful for detecting early glaucoma

May 6, 2016
NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, Vikas Chopra, MD, describes the advantages of microperimetry over standard perimetry…
More News Headlines »
Clinical Science

Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema

Ophthalmic Surgery, Lasers and Imaging Retina, April 2016, Volume 47 Issue 4
The diabetic macular edema (DME) treatment paradigm has evolved as the understanding of the disease pathology has…
More »
CME

Central and Branch Retinal Vein Occlusion Clinical Trials: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Highlights from ASCRS

Highlights from ASCRS

Video
Meeting News Coverage

VIDEO: New data show long-term patient satisfaction with premium IOLs

May 6, 2016
More »
morganatic-roan morganatic-roan